Sector
PharmaceuticalsOpen
₹149.7Prev. Close
₹146.6Turnover(Lac.)
₹1.8Day's High
₹154.75Day's Low
₹14852 Week's High
₹184.352 Week's Low
₹105Book Value
₹87.19Face Value
₹10Mkt Cap (₹ Cr.)
88.12P/E
0EPS
0Divi. Yield
010 Jul 2024
12:00 AM
AGM
Announcement Date: 10 Jul, 2024
22 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.9 | 5.9 | 4.92 | 4.92 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 45.55 | 52.38 | 45.38 | 44.7 |
Net Worth | 51.45 | 58.28 | 50.3 | 49.62 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 44.34 | 51.3 | 55.94 | 58.13 |
yoy growth (%) | -13.56 | -8.29 | -3.75 | -5.33 |
Raw materials | -22.46 | -29.5 | -35.91 | -34.69 |
As % of sales | 50.65 | 57.51 | 64.2 | 59.68 |
Employee costs | -7.63 | -7.83 | -6.28 | -6.62 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -2.07 | 0.24 | 4.23 | 4.55 |
Depreciation | -4.19 | -1.98 | -1.57 | -1.07 |
Tax paid | 0.45 | -0.37 | -1.17 | -1.63 |
Working capital | 0.97 | -2.97 | 1.06 | -1.99 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -13.56 | -8.29 | -3.75 | -5.33 |
Op profit growth | 21.46 | -39.3 | -14.22 | 17.01 |
EBIT growth | -150.95 | -79.27 | -4.77 | 26.16 |
Net profit growth | 1,205.81 | -104.04 | -17.37 | 60.43 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Gross Sales | 104.39 | 101.28 | 126.63 | 68.64 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 104.39 | 101.28 | 126.63 | 68.64 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 1.53 | 2.28 | 3.19 | 0.96 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,887.4 | 166.48 | 4,63,359.57 | 237.82 | 0.7 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,940.5 | 95.69 | 1,58,942.68 | 430 | 0.5 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,618.55 | 34.18 | 1,35,756.05 | 1,055.94 | 0.77 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,444.15 | 80.13 | 1,20,438.86 | 469 | 0.79 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,582.45 | 27.01 | 1,11,289.4 | 1,417.2 | 0.6 | 5,823.9 | 1,458.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
R K P Verma
Independent Non Exe. Director
Dipti Shah
Independent Non Exe. Director
Vishal Jain
Non-Exec & Non-Independent Dir
Prashant Godha
Whole-time Director
Saahil U Parikh
Whole-time Director
Nilesh Jain
Company Sec. & Compli. Officer
Piyush Ajmera
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Makers Laboratories Ltd
Summary
Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984. The Company was promoted by Satish Kumar Gupta and Naval Tated. The Company is presently in manufacture of pharmaceutical formulations and drug intermediates.Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993. As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL.During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit.MLL has gone for expansion in the year 1999. It has increased the installed capacity of Tablets & Capsules by 13.25 crores(Nos) and the company has again expanded the installed capacity of Tablets & Capsules in the year 2000 by 15.00 crores(Nos),taking the total capacity to 60.00 crores.The Modernisation of Formulation Drugs which was undertaken during 1999-2000 was completed successfully and this project was financed through Rights Issue of Equity Shares.The Palghar Plant Liquid Department was upgraded under the standard of schedule M during 2004. The Company sold its unviable formulations manufacturing unit at Palghar, in Thane Dist. during 2008. Harleystreet Pha
Read More
What is the Makers Laboratories Ltd share price today?
The Makers Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹149.35 today.
What is the Market Cap of Makers Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Makers Laboratories Ltd is ₹88.12 Cr. as of 10 Oct ‘24
What is the PE and PB ratio of Makers Laboratories Ltd?
The PE and PB ratios of Makers Laboratories Ltd is 0 and 1.68 as of 10 Oct ‘24
What is the 52 Week High and Low of Makers Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Makers Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Makers Laboratories Ltd is ₹105 and ₹184.3 as of 10 Oct ‘24
What is the CAGR of Makers Laboratories Ltd?
Makers Laboratories Ltd's CAGR for 5 Years at 32.05%, 3 Years at -10.24%, 1 Year at 34.56%, 6 Month at 11.44%, 3 Month at 9.77% and 1 Month at -5.66%.
What is the shareholding pattern of Makers Laboratories Ltd?
The shareholding pattern of Makers Laboratories Ltd is as follows:
Promoters - 61.27 %
Institutions - 0.39 %
Public - 38.34 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
